Bernhard Gentner

6.6k total citations · 3 hit papers
80 papers, 4.1k citations indexed

About

Bernhard Gentner is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Bernhard Gentner has authored 80 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Molecular Biology, 22 papers in Genetics and 22 papers in Cancer Research. Recurrent topics in Bernhard Gentner's work include RNA Interference and Gene Delivery (23 papers), Virus-based gene therapy research (21 papers) and MicroRNA in disease regulation (18 papers). Bernhard Gentner is often cited by papers focused on RNA Interference and Gene Delivery (23 papers), Virus-based gene therapy research (21 papers) and MicroRNA in disease regulation (18 papers). Bernhard Gentner collaborates with scholars based in Italy, United States and Switzerland. Bernhard Gentner's co-authors include Luigi Naldini, Mario Amendola, Roberta Mazzieri, Erika Zonari, Brian D. Brown, Davide Moi, Ferdinando Pucci, Alice Giustacchini, Anna Ranghetti and Letterio S. Politi and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Bernhard Gentner

75 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeting the ANG2/TIE2 Axis Inhibits Tumor Growth and Metastasis by Impairing Angiogenesis and Disabling Rebounds of Proangiogenic Myeloid Cells

2011 489 citations Roberta Mazzieri, Erika Zonari et al. profile →
Targeted genome editing in human repopulating haematopoietic stem cells

2014 434 citations Giulia Escobar, Andrea Calabria et al. profile →
Genotoxic effects of base and prime editing in human hematopoietic stem cells

2023 93 citations Samuele Ferrari, Attya Omer et al. Nature Biotechnology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bernhard Gentner Italy	29	2.7k	1.2k	1.1k	1.0k	927	80	4.1k
Lucia Sergi Sergi Italy	19	2.4k 0.9×	546 0.5×	1.1k 0.9×	1.6k 1.5×	758 0.8×	25	3.5k
Olivier Lefèbvre France	33	1.7k 0.6×	934 0.8×	904 0.8×	369 0.4×	551 0.6×	68	3.6k
Branden S. Moriarity United States	29	2.5k 1.0×	798 0.7×	1.4k 1.3×	579 0.6×	1.1k 1.2×	95	4.2k
Jin‐Yuh Shew Taiwan	23	2.7k 1.0×	934 0.8×	3.1k 2.8×	1.1k 1.1×	582 0.6×	32	5.2k
Valérie Kouskoff United Kingdom	42	4.6k 1.7×	539 0.5×	516 0.5×	467 0.5×	2.0k 2.1×	96	7.2k
Vimla Band United States	31	2.8k 1.0×	568 0.5×	1.4k 1.3×	430 0.4×	430 0.5×	70	4.2k
Bradley S. Cobb United Kingdom	28	4.8k 1.8×	2.2k 1.9×	749 0.7×	623 0.6×	2.1k 2.2×	43	8.0k
Jamie J. Newman United States	12	5.5k 2.1×	2.1k 1.8×	1.2k 1.1×	472 0.5×	488 0.5×	21	6.6k
Fedor Berditchevski United Kingdom	40	2.7k 1.0×	614 0.5×	729 0.7×	198 0.2×	1.1k 1.2×	72	5.5k
S Munemitsu United States	24	5.1k 1.9×	382 0.3×	1.3k 1.1×	893 0.9×	797 0.9×	28	7.1k

Countries citing papers authored by Bernhard Gentner

Since Specialization

Citations

This map shows the geographic impact of Bernhard Gentner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernhard Gentner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernhard Gentner more than expected).

Fields of papers citing papers by Bernhard Gentner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernhard Gentner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernhard Gentner. The network helps show where Bernhard Gentner may publish in the future.

Co-authorship network of co-authors of Bernhard Gentner

This figure shows the co-authorship network connecting the top 25 collaborators of Bernhard Gentner. A scholar is included among the top collaborators of Bernhard Gentner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernhard Gentner. Bernhard Gentner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hafezi, Morteza, Greta Maria Paola Giordano Attianese, Patrick Reichenbach, et al.. (2025). DNA-dependent protein kinase inhibitors PI-103 and samotolisib augment CRISPR/Cas9 knock-in efficiency in human T cells. Cytotherapy. 27(6). 766–773. 1 indexed citations

Rossari, Federico, Giorgia Alvisi, Melania Cusimano, et al.. (2025). A cross-talk established by tumor-targeted cytokines rescues CAR T cell activity and engages host T cells against glioblastoma in mice. Science Translational Medicine. 17(805). eado9511–eado9511. 1 indexed citations

Bartolini, Robin, Lionel Trueb, Douglas Daoudlarian, et al.. (2025). Enrichment of CD7+CXCR3+ CAR T-cells in infusion products is associated with durable remission in relapsed or refractory diffuse large B-cell lymphoma. Annals of Oncology. 36(7). 749–761. 1 indexed citations

Hafezi, Morteza, Raphaël Genolet, Sara Bobisse, et al.. (2025). Highly efficient gene knockout in tumor-infiltrating lymphocytes by adenine base editing. PubMed. 33(3). 201041–201041.

Rossari, Federico, Gualtiero Alvisi, Michael D. Cusimano, et al.. (2024). 52P Tumor-targeted cytokine release by genetically-engineered myeloid cells rescues CAR-T activity and engages endogenous T cells against high-grade glioma in mouse models. Immuno-Oncology Technology. 24. 100863–100863.

Ciceri, Fabio, Francesca Farina, Bernhard Gentner, et al.. (2024). 449MO Macrophage derived immunotherapy in glioblastoma: Phase I TEM-GBM-001 results. Annals of Oncology. 35. S409–S409.

Beretta, Stefano, Federico Rossari, Nadia Coltella, et al.. (2023). The transcription factor HIF2α partakes in the differentiation block of acute myeloid leukemia. EMBO Molecular Medicine. 15(11). e17810–e17810. 6 indexed citations

Ferrari, Samuele, Attya Omer, Stefano Beretta, et al.. (2023). Genotoxic effects of base and prime editing in human hematopoietic stem cells. Nature Biotechnology. 42(6). 877–891. 93 indexed citations breakdown →

Pievani, Alice, Giacomo Desantis, Laura Antolini, et al.. (2022). CD14 positive cells accelerate hematopoietic stem cell engraftment. Bone Marrow Transplantation. 57(6). 942–948. 3 indexed citations

10.

Mucci, Adele, Gabriele Antonarelli, Giacomo Desantis, et al.. (2021). Myeloid cell‐based delivery of IFN‐γ reprograms the leukemia microenvironment and induces anti‐tumoral immune responses. EMBO Molecular Medicine. 13(10). e13598–e13598. 20 indexed citations

11.

Antolini, Laura, Carlo Gambacorti‐Passerini, Bernhard Gentner, et al.. (2019). Acute myeloid leukaemia niche regulates response to L‐asparaginase. British Journal of Haematology. 186(3). 420–430. 19 indexed citations

12.

Petrillo, Carolina, Andrea Calabria, Alessia Capotondo, et al.. (2019). Assessing the Impact of Cyclosporin A on Lentiviral Transduction and Preservation of Human Hematopoietic Stem Cells in Clinically Relevant Ex Vivo Gene Therapy Settings. Human Gene Therapy. 30(9). 1133–1146. 8 indexed citations

13.

Crisafulli, Laura, Sharon Muggeo, Paolo Uva, et al.. (2019). MicroRNA-127-3p controls murine hematopoietic stem cell maintenance by limiting differentiation. Haematologica. 104(9). 1744–1755. 14 indexed citations

14.

Chiriacò, Maria Serena, Fabio Casciano, Gigliola Di Matteo, et al.. (2018). Impaired X-CGD T cell compartment is gp91phox-NADPH oxidase independent. Clinical Immunology. 193. 52–59. 7 indexed citations

15.

Escobar, Giulia, Bernhard Gentner, Luigi Naldini, & Roberta Mazzieri. (2014). Engineered tumor-infiltrating macrophages as gene delivery vehicles for interferon-α activates immunity and inhibits breast cancer progression. OncoImmunology. 3(5). e28696–e28696. 18 indexed citations

16.

Åkerblom, Malin, Rohit Sachdeva, Isabelle Barde, et al.. (2012). MicroRNA-124 Is a Subventricular Zone Neuronal Fate Determinant. Journal of Neuroscience. 32(26). 8879–8889. 157 indexed citations

17.

Lechman, Eric R., Bernhard Gentner, Peter van Galen, et al.. (2012). Attenuation of miR-126 Activity Expands HSC In Vivo without Exhaustion. Cell stem cell. 11(6). 799–811. 154 indexed citations

18.

Lachmann, Nico, Dirk Heckl, Sebastian Brennig, et al.. (2011). MicroRNA-150-regulated vectors allow lymphocyte-sparing transgene expression in hematopoietic gene therapy. Gene Therapy. 19(9). 915–924. 13 indexed citations

19.

Gentner, Bernhard, Axel Wein, Roland S. Croner, et al.. (2009). Differences in the gene expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in primary colorectal tumors and their synchronous liver metastases.. PubMed. 29(1). 67–74. 30 indexed citations

20.

Brown, Brian D., Bernhard Gentner, Alessio Cantore, et al.. (2007). Endogenous microRNA can be broadly exploited to regulate transgene expression according to tissue, lineage and differentiation state. Nature Biotechnology. 25(12). 1457–1467. 449 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact